RxDoctor Payments Data

Lawrence Mactavish

Podiatrist · Houston, TXNPI 1104858885

Payments from drug & device makers

What this record shows

This record is dominated by other: $34,344 of the $40,644 with a category attached, or 84.5%. Convatec Inc. accounts for 65.6% of it on its own, with 36 other manufacturers making up the rest. Reporting peaked in 2024 at $27,378 and has fallen 92.3% since, to $2,110 in 2025. Among podiatrist clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$40,644in general payments, 2019–2025

Across 122 payments — averaging $333.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Convatec Inc.$27K
  • Triad Life Sciences Inc.$8K
  • Treace Medical Concepts, Inc.$2K
  • Trimed, Inc.$1K
  • Sanara Medtech Inc.$794
  • Stryker$765
  • plus $2K from 31 others

What the payments were for

  • Travel & lodging$1,3013%
  • Food & beverage$4,99912%
  • Other$34,34484%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$40,644 in reported general payments places this provider in the 90th percentile of 470 podiatrist providers in Texas.

See all podiatrist providers in Texas

Medicare billing

Part B allowed, 2024
$907,404
Medicare patients
238
Services billed
4,588

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-IbuprofenHydrocodone/Ibuprofen12$1,489
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen74$932
Etodolac18$541
Ciclopirox19$506
Terbinafine Hcl59$456
Methylprednisolone60$387
Amitriptyline Hcl39$308
Gabapentin14$292
Meloxicam95$292
Celecoxib26$260
Ketoconazole15$240
Cephalexin59$236
Mupirocin11$111
Triamcinolone Acetonide12$107
Tramadol Hcl26$88

Paid to pharmacies, not to this prescriber.

Other podiatrist in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →